PATENT CLAIM ANALYSIS

Application Number: 16083210
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "275000"]

Abstract:
Forms I and II of the mesylate salt of the compound of formula (I), a preparation methods thereof, a pharmaceutical composition containing the crystal forms, and the use of the crystal forms in treating diseases mediated by activating and resistance mutations of EGFR, in particular cancer, in mammal, in particular in human. The crystal forms of the mesylate salt of the compound of formula (I) have good solubilities and high bioavailabilities in animals.

Claim (Index 2):
Form I according to  claim 1 , which has an X-ray powder diffraction pattern that is substantially identical to that in  FIG. 1 .

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.93182
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16083209', '15328795', '15649068', '14576721', '15329044']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7556879065401997
- 35 USC 102 Novelty (BERT): 0.5353936553033627
- Combined Prediction Score: 0.7336584814165159
- Mean Citation Score: 276.107134
- Max Citation Score: 318.22372
- Similarity Product: 176.5401362872982

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test